Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/2002
05/02/2002WO2001089450A3 Treating musculoskeletal disorders using lp85 and analogs thereof
05/02/2002WO2001077137A9 Albumin fusion proteins
05/02/2002WO2001072778A3 Method of identifying inhibitors of tie-2
05/02/2002WO2001064749A3 Method for preparing anti-mif antibodies
05/02/2002WO2001055210A3 Human cyr61
05/02/2002WO2001052829A3 Statin-type bone growth stimulators
05/02/2002WO2001044264A3 Novel stromelysin inhibitors
05/02/2002WO2001040253A3 3-methylene steroid derivative for the treatment of autoimmune diseases
05/02/2002WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
05/02/2002WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/02/2002WO2001018172A3 Fibroblast growth factor-like polypeptides
05/02/2002WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors
05/02/2002US20020052527 Novel process for preparing alendronic acid
05/02/2002US20020052513 Oxamide IMPDH inhibitors
05/02/2002US20020052512 Diaminopropionic acid derivatives
05/02/2002US20020052504 N-((2-cyclopropoxy-5-(1H-tetrazol-1-))phenyl)methyl-2-(4 -phenyl)piperidin-3-amine and derivatives; in particular as neurokinin-1 receptor antagonists; analgesics; migraines; antiinflammatory, anxiolytic, emetic agents; antidepressants
05/02/2002US20020052475 Cytokines for use in the treatment of autoimmune disease, inflammation, arthritis and multiple sclerosis
05/02/2002US20020052409 Compounds and methods for treating mitochondria-associated diseases
05/02/2002US20020052398 Pharmaceutical composition of 6-amino EM-12
05/02/2002US20020052387 5-Substituted 2-aryl-4-pyrimidinones
05/02/2002US20020052386 Pyrimidine derivatives
05/02/2002US20020052378 Novel compounds and compositions as protease inhibitors
05/02/2002US20020052369 Indolinone derivatives as protein kinase/phosphatase inhibitors
05/02/2002US20020052358 Methods and compositions related to modulators of annexin and cartilage homeostasis
05/02/2002US20020052356 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity.
05/02/2002US20020052350 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses
05/02/2002US20020052349 p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents
05/02/2002US20020052337 Composition and method for inhibiting platelet aggregation
05/02/2002US20020052323 Protease inhibitors, particularly for caspase enzyme; treating arthritis, ALS, MS, and the like.
05/02/2002US20020052311 Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders
05/02/2002US20020052027 IL-17 homologous polypeptides and therapeutic uses thereof
05/02/2002US20020051969 Modulatory polypeptide; for use in the treatment of bone disorders
05/02/2002US20020051822 Enhancing bone formation, inhibiting osteoclastic differentiation or activating osteoblastic differentialation by administering to a human or animal suffering from, or susceptible to bone disease a lanthanum compound
05/02/2002US20020051771 Apoptotic entities for use in treatment of T-cell-mediated and inflammatory disorders
05/02/2002EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression.
05/02/2002EP1201639A2 Lipoxin compounds and their use in treating cell proliferative disorders
05/02/2002EP1201241A2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
05/02/2002EP1201237A1 Composition comprising an amide or a dialkylsulphoxide derivative for the treatment of cancer
05/02/2002EP1201231A2 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticle, and therapeutic agent for treating zinc deficiency
05/02/2002EP1200596A2 Human synthetases
05/02/2002EP1200595A2 Myxoma virus genes for immune modulation
05/02/2002EP1200593A2 The il-1l1 gene and polypeptide products
05/02/2002EP1200587A2 Receptors and associated proteins
05/02/2002EP1200586A2 Human nervous system-associated proteins
05/02/2002EP1200584A1 Splice variants of cd40-receptor
05/02/2002EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins
05/02/2002EP1200570A1 Antisense modulation of p13 kinase p110 delta expression
05/02/2002EP1200560A1 Melanin-concentrating hormone receptor
05/02/2002EP1200555A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
05/02/2002EP1200462A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands
05/02/2002EP1200457A2 Cysteine protease inhibitors
05/02/2002EP1200440A1 Quinuclidine derivatives for treatment of neurological disorders
05/02/2002EP1200438A2 Method for making debromohymenialdisine and analogs thereof
05/02/2002EP1200432A1 Amido spiropiperidines promote the release of growth hormone
05/02/2002EP1200422A2 Pyrazole compositions useful as inhibitors of erk
05/02/2002EP1200419A1 Aminothiazole derivatives and their use as crf receptor ligands
05/02/2002EP1200399A1 Vitamin d3 analogs
05/02/2002EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors
05/02/2002EP1200127A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation
05/02/2002EP1200106A1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
05/02/2002EP1200086A2 Methods for treating or preventing pain and anxiety
05/02/2002EP1200085A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
05/02/2002EP1200076A1 Calcilytic compounds
05/02/2002EP0931086B1 Tetrahydronaphthalene derivatives and their therapeutic use
05/02/2002DE10052658A1 Neue Pyranosidderivate New Pyranosidderivate
05/02/2002DE10052333A1 Neue Sulfooxybenzamide New Sulfooxybenzamide
05/02/2002DE10049549A1 Inhibitor of the transcription factor IFR-1, useful for treating e.g. transplant rejection and autoimmune disease, reduces expression of CD40
05/02/2002CA2678256A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
05/02/2002CA2427085A1 Transmembrane proteins
05/02/2002CA2427024A1 Methods for screening compounds that modulate lipid metabolism
05/02/2002CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
05/02/2002CA2426736A1 Vegf peptides and their use for inhibiting angiogenesis
05/02/2002CA2426564A1 Pyranoside derivatives
05/02/2002CA2426463A1 Novel aggrecanase molecules
05/02/2002CA2426244A1 Lipid formulations for target delivery
05/02/2002CA2426007A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
05/02/2002CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity
05/02/2002CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/02/2002CA2425280A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/02/2002CA2421885A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
05/02/2002CA2420164A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors
05/01/2002CN1347420A Growth hormone secretagogues
05/01/2002CN1347411A Sulfonamide derivs. having oxadiazole rings
05/01/2002CN1347325A Novel amide derivs. as growth hormone secretagogues
05/01/2002CN1347323A Chemical compounds
05/01/2002CN1347322A Chemical compounds
05/01/2002CN1347318A Inhibitors of IMPDH enzyme
05/01/2002CN1346673A Chinese patent medicine for treating hyperosteogeny
05/01/2002CN1346670A Medicine for treating hyperosteogeny
05/01/2002CN1346661A Medicine for setting up bone
05/01/2002CN1346655A Liquid medicine for treating traumatic injury
05/01/2002CN1346647A Quick-acting antalgic plaster for detumescence and detoxication
05/01/2002CN1346644A Oral Chinese medicine for treating bone fracture
05/01/2002CN1083722C Plaster for treating hyperosteogeny and protrusion of lumbar vertebral disc
04/2002
04/30/2002US6380396 Chemical intermediates for antiinflammatory agents
04/30/2002US6380374 Isolated nucleic acid; culture product
04/30/2002US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
04/30/2002US6380251 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives
04/30/2002US6380250 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives
04/30/2002US6380223 For therapy of diseases, such as obesity, diabetes, inflammation